In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Spyre Therapeutics Inc (NASDAQ: SYRE) closed the day trading at $22.07 down -3.71% from the previous closing price of $22.92. In other words, the price has decreased by -$3.71 from its previous closing price. On the day, 0.63 million shares were traded.
Ratios:
For a better understanding of SYRE, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.32 and its Current Ratio is at 7.32. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on September 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $45.
On May 02, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $50.Robert W. Baird initiated its Outperform rating on May 02, 2024, with a $50 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 06 ’24 when Albers Jeffrey W. sold 6,700 shares for $36.76 per share. The transaction valued at 246,313 led to the insider holds 27,360 shares of the business.
Albers Jeffrey W. sold 300 shares of SYRE for $10,929 on Oct 25 ’24. The Director now owns 34,060 shares after completing the transaction at $36.43 per share. On Oct 25 ’24, another insider, SESSIONS, LLC, who serves as the Director of the company, bought 7,000 shares for $33.70 each.
Valuation Measures:
As of this moment, Spyre’s Price-to-Earnings (P/E) ratio for their current fiscal year is 2.40. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.04.
Stock Price History:
Over the past 52 weeks, SYRE has reached a high of $47.97, while it has fallen to a 52-week low of $20.07. The 50-Day Moving Average of the stock is -5.45%, while the 200-Day Moving Average is calculated to be -22.61%.
Shares Statistics:
A total of 51.40M shares are outstanding, with a floating share count of 48.60M. Insiders hold about 17.21% of the company’s shares, while institutions hold 96.03% stake in the company.
Earnings Estimates
The firm’s stock currently is rated by 7.0 analysts. The consensus estimate for the next quarter is -$0.79, with high estimates of -$0.6 and low estimates of -$1.05.
Analysts are recommending an EPS of between -$3.97 and -$4.55 for the fiscal current year, implying an average EPS of -$4.3. EPS for the following year is -$3.95, with 7.0 analysts recommending between -$2.81 and -$4.86.
